SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-159797
Filing Date
2009-07-31
Accepted
2009-07-30 19:31:58
Documents
6
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 550886
2 AMENDED AND RESTATED 2005 EQUITY INCENTIVE PLAN dex101.htm EX-10.1 221277
3 CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 5966
4 CERTIFICATION OF PFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 5945
5 CERTIFICATION BY THE PEO AND PFO AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 3351
6 GRAPHIC g12893g31i63.jpg GRAPHIC 13202
  Complete submission text file 0001193125-09-159797.txt   807276
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 09975112
SIC: 2836 Biological Products, (No Diagnostic Substances)